Literature DB >> 2378287

Relapse situations and self-efficacy: an integrative model.

W F Velicer1, C C Diclemente, J S Rossi, J O Prochaska.   

Abstract

Researchers studying relapse for an addictive behavior have employed two different conceptual models. Researchers concerned with typologies of relapse situations have developed a variety of discrete classes of high risk situations. Researchers who have employed a Self-efficacy approach have typically assessed different situations but scored the measure as a single general construct. Using structural modeling, this paper evaluates five alternative measurement models, representing alternative conceptualizations. A hierarchical model which integrates the previously competing models provided the best fit to the data and serves to explain a large body of previous findings. The model includes three first order constructs (Positive/Social; Negative/Affective; and Habit/Addictive) and one general second-order factor. The results were replicated across two different response formats and two different subject samples.

Mesh:

Year:  1990        PMID: 2378287     DOI: 10.1016/0306-4603(90)90070-e

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  249 in total

1.  Cluster randomised controlled trial of expert system based on the transtheoretical ("stages of change") model for smoking prevention and cessation in schools.

Authors:  P Aveyard; K K Cheng; J Almond; E Sherratt; R Lancashire; T Lawrence; C Griffin; O Evans
Journal:  BMJ       Date:  1999-10-09

2.  Behavior-changing methods for improving adherence to medication.

Authors:  C Willey
Journal:  Curr Hypertens Rep       Date:  1999-12       Impact factor: 5.369

3.  A randomized, controlled trial of NRT-aided gradual vs. abrupt cessation in smokers actively trying to quit.

Authors:  John R Hughes; Laura J Solomon; Amy E Livingston; Peter W Callas; Erica N Peters
Journal:  Drug Alcohol Depend       Date:  2010-05-26       Impact factor: 4.492

4.  Factor structure of decisional balance and temptations scales for smoking: cross-validation in urban female African-American adolescents.

Authors:  Bettina B Hoeppner; Colleen A Redding; Joseph S Rossi; Unto E Pallonen; James O Prochaska; Wayne F Velicer
Journal:  Int J Behav Med       Date:  2012-06

5.  Smoking outcome expectancies in military veteran smokers with posttraumatic stress disorder.

Authors:  Timothy P Carmody; Miles McFall; Andrew J Saxon; Carol A Malte; Bruce Chow; Anne M Joseph; Jean C Beckham; Jessica W Cook
Journal:  Nicotine Tob Res       Date:  2012-01-23       Impact factor: 4.244

6.  Self-efficacy and barriers to multiple behavior change in low-income African Americans with hypertension.

Authors:  Carol L Mansyur; Valory N Pavlik; David J Hyman; Wendell C Taylor; G Kenneth Goodrick
Journal:  J Behav Med       Date:  2012-02-10

7.  Trial design: blood pressure control and weight gain prevention in prehypertensive and hypertensive smokers: the treatment and prevention study.

Authors:  Mark W Vander Weg; Robert C Klesges; Jon O Ebbert; Ellen J Lichty; Margaret DeBon; Frederick North; Darrell R Schroeder; Patricia M Dubbert
Journal:  Contemp Clin Trials       Date:  2007-07-19       Impact factor: 2.226

8.  Smoking behavior and motivation to quit among chronic pain patients initiating multidisciplinary pain treatment: a prospective study.

Authors:  Marina Unrod; Ronald J Gironda; Michael E Clark; Kristi E White; Vani N Simmons; Steven K Sutton; Thomas H Brandon
Journal:  Pain Med       Date:  2014-02-15       Impact factor: 3.750

9.  Motivational interviewing versus brief advice for cigarette smokers in residential alcohol treatment.

Authors:  Damaris J Rohsenow; Rosemarie A Martin; Peter M Monti; Suzanne M Colby; Anne M Day; David B Abrams; Alan D Sirota; Robert M Swift
Journal:  J Subst Abuse Treat       Date:  2013-10-14

10.  Use of non-assigned interventions in a randomized trial of internet and telephone treatment for smoking cessation.

Authors:  Caroline O Cobb; Amanda L Graham
Journal:  Nicotine Tob Res       Date:  2014-05-08       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.